[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Polypeptide Drug Sales Market Report Forecast 2017-2022

April 2017 | 103 pages | ID: G7FE2B6C810EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
  • United States
  • China
  • Europe
  • Japan
The Major players reported in the market include:

Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda

Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
Application Segment Analysis:
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified analysis of major market segments
1 POLYPEPTIDE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Classification of Polypeptide Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Polypeptide Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Polypeptide Drug Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Polypeptide Drug (2012-2022)
  1.5.1 Global Polypeptide Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Polypeptide Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON POLYPEPTIDE DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 POLYPEPTIDE DRUG MANUFACTURING COST ANALYSIS

3.1 Polypeptide Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Polypeptide Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Polypeptide Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL POLYPEPTIDE DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Polypeptide Drug Market Competition by Manufacturers
  5.1.1 Global Polypeptide Drug Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Polypeptide Drug Revenue and Share by Manufacturers (2012-2017)
5.2 Global Polypeptide Drug (Volume and Value) by Type
  5.5.1 Global Polypeptide Drug Sales and Market Share by Type (2012-2017)
  5.5.2 Global Polypeptide Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Polypeptide Drug (Volume and Value) by Regions
  5.3.1 Global Polypeptide Drug Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Polypeptide Drug Revenue and Market Share by Regions (2012-2017)
5.4 Global Polypeptide Drug (Volume) by Application

6 UNITED STATES POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 United States Polypeptide Drug Sales and Value (2012-2017)
  6.1.1 United States Polypeptide Drug Sales and Growth Rate (2012-2017)
  6.1.2 United States Polypeptide Drug Revenue and Growth Rate (2012-2017)
  6.1.3 United States Polypeptide Drug Sales Price Trend (2012-2017)
6.2 United States Polypeptide Drug Sales and Market Share by Manufacturers
6.3 United States Polypeptide Drug Sales and Market Share by Type
6.4 United States Polypeptide Drug Sales and Market Share by Application

7 CHINA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 China Polypeptide Drug Sales and Value (2012-2017)
  7.1.1 China Polypeptide Drug Sales and Growth Rate (2012-2017)
  7.1.2 China Polypeptide Drug Revenue and Growth Rate (2012-2017)
  7.1.3 China Polypeptide Drug Sales Price Trend (2012-2017)
7.2 China Polypeptide Drug Sales and Market Share by Manufacturers
7.3 China Polypeptide Drug Sales and Market Share by Type
7.4 China Polypeptide Drug Sales and Market Share by Application

8 EUROPE POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Polypeptide Drug Sales and Value (2012-2017)
  8.1.1 Europe Polypeptide Drug Sales and Growth Rate (2012-2017)
  8.1.2 Europe Polypeptide Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Polypeptide Drug Sales Price Trend (2012-2017)
8.2 Europe Polypeptide Drug Sales and Market Share by Manufacturers
8.3 Europe Polypeptide Drug Sales and Market Share by Type
8.4 Europe Polypeptide Drug Sales and Market Share by Application

9 JAPAN POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Polypeptide Drug Sales and Value (2012-2017)
  9.1.1 Japan Polypeptide Drug Sales and Growth Rate (2012-2017)
  9.1.2 Japan Polypeptide Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Polypeptide Drug Sales Price Trend (2012-2017)
9.2 Japan Polypeptide Drug Sales and Market Share by Manufacturers
9.3 Japan Polypeptide Drug Sales and Market Share by Type
9.4 Japan Polypeptide Drug Sales and Market Share by Application

10 GLOBAL POLYPEPTIDE DRUG MANUFACTURERS ANALYSIS

10.1 Novartis
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Merck Serono
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Ferring Pharmaceuticals
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Ipsen PHarma Biotech
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Lilly
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Asahi Kasei
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 AstraZeneca
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 SciClone Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Takeda
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

...

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL POLYPEPTIDE DRUG MARKET FORECAST (2017-2022)

13.1 Global Polypeptide Drug Sales, Revenue Forecast (2017-2022)
13.2 Global Polypeptide Drug Sales Forecast by Regions (2017-2022)
13.3 Global Polypeptide Drug Sales Forecast by Type (2017-2022)
13.4 Global Polypeptide Drug Sales Forecast by Application (2017-2022)

14 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Polypeptide Drug
Table Classification of Polypeptide Drug
Figure Global Sales Market Share of Polypeptide Drug by Type in 2016
Table Applications of Polypeptide Drug
Figure Global Sales Market Share of Polypeptide Drug by Application in 2016
Figure United States Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure China Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Europe Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Japan Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Global Polypeptide Drug Sales and Growth Rate (2012-2022)
Figure Global Polypeptide Drug Revenue and Growth Rate (2012-2022)
Table Global Polypeptide Drug Sales of Key Manufacturers (2012-2017)
Table Global Polypeptide Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Polypeptide Drug Sales Share by Manufacturers
Figure 2016 Polypeptide Drug Sales Share by Manufacturers
Table Global Polypeptide Drug Revenue by Manufacturers (2012-2017)
Table Global Polypeptide Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Polypeptide Drug Revenue Share by Manufacturers
Table 2016 Global Polypeptide Drug Revenue Share by Manufacturers
Table Global Polypeptide Drug Sales and Market Share by Type (2012-2017)
Table Global Polypeptide Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Type (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Type (2012-2017)
Table Global Polypeptide Drug Revenue and Market Share by Type (2012-2017)
Table Global Polypeptide Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Type (2012-2017)
Figure Global Polypeptide Drug Revenue Growth Rate by Type (2012-2017)
Table Global Polypeptide Drug Sales and Market Share by Regions (2012-2017)
Table Global Polypeptide Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Regions (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Regions (2012-2017)
Table Global Polypeptide Drug Revenue and Market Share by Regions (2012-2017)
Table Global Polypeptide Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Regions (2012-2017)
Figure Global Polypeptide Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Polypeptide Drug Sales and Market Share by Application (2012-2017)
Table Global Polypeptide Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Application (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Application (2012-2017)
Figure United States Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure United States Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure United States Polypeptide Drug Sales Price Trend (2012-2017)
Table United States Polypeptide Drug Sales by Manufacturers (2012-2017)
Table United States Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table United States Polypeptide Drug Sales by Type (2012-2017)
Table United States Polypeptide Drug Market Share by Type (2012-2017)
Table United States Polypeptide Drug Sales by Application (2012-2017)
Table United States Polypeptide Drug Market Share by Application (2012-2017)
Figure China Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure China Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure China Polypeptide Drug Sales Price Trend (2012-2017)
Table China Polypeptide Drug Sales by Manufacturers (2012-2017)
Table China Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table China Polypeptide Drug Sales by Type (2012-2017)
Table China Polypeptide Drug Market Share by Type (2012-2017)
Table China Polypeptide Drug Sales by Application (2012-2017)
Table China Polypeptide Drug Market Share by Application (2012-2017)
Figure Europe Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Europe Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Europe Polypeptide Drug Sales Price Trend (2012-2017)
Table Europe Polypeptide Drug Sales by Manufacturers (2012-2017)
Table Europe Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table Europe Polypeptide Drug Sales by Type (2012-2017)
Table Europe Polypeptide Drug Market Share by Type (2012-2017)
Table Europe Polypeptide Drug Sales by Application (2012-2017)
Table Europe Polypeptide Drug Market Share by Application (2012-2017)
Figure Japan Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Japan Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Japan Polypeptide Drug Sales Price Trend (2012-2017)
Table Japan Polypeptide Drug Sales by Manufacturers (2012-2017)
Table Japan Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table Japan Polypeptide Drug Sales by Type (2012-2017)
Table Japan Polypeptide Drug Market Share by Type (2012-2017)
Table Japan Polypeptide Drug Sales by Application (2012-2017)
Table Japan Polypeptide Drug Market Share by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Polypeptide Drug Global Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Serono Polypeptide Drug Global Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information List
Table Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Polypeptide Drug Global Market Share (2012-2017)
Table Ipsen PHarma Biotech Basic Information List
Table Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ipsen PHarma Biotech Polypeptide Drug Global Market Share (2012-2017)
Table Lilly Basic Information List
Table Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lilly Polypeptide Drug Global Market Share (2012-2017)
Table Asahi Kasei Basic Information List
Table Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Asahi Kasei Polypeptide Drug Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Polypeptide Drug Global Market Share (2012-2017)
Table SciClone Pharmaceuticals Basic Information List
Table SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SciClone Pharmaceuticals Polypeptide Drug Global Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Polypeptide Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2016
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure Global Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Regions (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Type (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Application (2017-2022)


More Publications